SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,231.00    7.00 (0.57%)
Bid:
1,229.00
Ask:
1,230.00
Spread: 1.00 (0.081%)
Market Cap: £858.56m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Acquisition

16 Mar 2010 07:00

RNS Number : 6217I
CVS Group plc
16 March 2010
 



 

CVS Group plc ("CVS" or the "Company")

16 March 2010

Acquisition of veterinary surgery

CVS, one of the UK's leading providers of veterinary services, is pleased to announce the acquisition of Goudhurst Veterinary Surgery and Equine clinic ("Goudhurst"), a single site veterinary surgery based in Kent.

The acquisition demonstrates the Company's strong pipeline of potential acquisition opportunities following the acquisition of Veterinary Enterprises and Trading Limited ("Veterinary Enterprises") earlier this month and increases the number of surgeries operated by CVS to 198.

CVS will assume all management responsibilities for Goudhurst following completion of the acquisition. In line with the Company's strategy, administration will be consolidated within the Company's central facilities, providing cost synergies and benefits following the acquisition.

In the year ended 31 March 2009, Goudhurst achieved profit before tax of GBP109,000 on turnover of approximately GBP503,000. The acquisition includes GBP43,000 of fixed assets at the March 2009 year end and CVS will also acquire the current stock. The consideration for the acquisition is being met entirely from internally generated cash. The practice has three professional vets and nine staff in total.

Commenting on the acquisition, CVS Chief Executive Simon Innes said: "Goudhurst is a quality well established practice and we are delighted to be continuing to add to our portfolio immediately following the completion of the acquisition of Veterinary Enterprises earlier this month. We look forward to working with the Goudhurst team to help them continue the high level of animal care and customer service that they have been delivering to date."

For further enquiries please contact:

CVS Group plc

Simon Innes, Chief Executive

Paul Coxon, Finance Director

01379 644 288

Brewin Dolphin Investment Banking

Richard Jones/Matt Davis

Paul Mason

0845 059 6740

Buchanan Communications

Richard Oldworth

Suzanne Brocks

020 7466 5000

Ends

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLFFLIVDIELII
Date   Source Headline
28th Feb 20259:57 amRNSTotal Voting Rights
27th Feb 20257:00 amRNSInterim Results
6th Feb 20259:24 amRNSStandard form for notification of major holdings
31st Jan 20257:00 amRNSTotal Voting Rights
30th Jan 20257:00 amRNSHalf Year Trading Update
13th Jan 20257:00 amRNSBlock listing Interim Review
7th Jan 20257:00 amRNSDirector/PDMR Shareholding
31st Dec 202410:52 amRNSTotal Voting Rights
29th Nov 20247:00 amRNSTotal Voting Rights
26th Nov 20241:59 pmRNSGrant of Options & PDMR Dealing
21st Nov 20244:05 pmRNSStandard form for notification of major holdings
20th Nov 202412:51 pmRNSResult of AGM
20th Nov 20247:00 amRNSAGM Statement and Trading Update
4th Nov 20249:18 amRNSStandard form for notification of major holdings
31st Oct 202411:35 amRNSExercise of Options and Total Voting Rights
30th Oct 20244:11 pmRNSStandard form for notification of major holdings
21st Oct 202410:42 amRNSPosting of Annual Report and Notice of AGM
16th Oct 202412:14 pmRNSStandard form for notification of major holdings
14th Oct 20242:34 pmRNSnotification of major holdings
11th Oct 20245:28 pmRNSHolding(s) in Company
4th Oct 20245:11 pmRNSLong Term Incentive Plan Awards and PDMR Dealing
3rd Oct 20247:00 amRNSNotification of major holdings
1st Oct 20247:00 amRNSTotal Voting Rights
26th Sep 20247:00 amRNSFinal results for the year ended 30 June 2024
2nd Sep 20242:45 pmRNSTotal Voting Rights
31st Jul 20247:00 amRNSTotal Voting Rights
30th Jul 20249:42 amRNSHolding(s) in Company
25th Jul 20247:00 amRNSTrading Statement
12th Jul 20247:00 amRNSBlock Listing Interim Review
11th Jul 20241:55 pmRNSPDMR Dealing
28th Jun 20247:00 amRNSExercise of Options and Total Voting Rights
27th Jun 20242:53 pmRNSDirector/PDMR Shareholding
24th Jun 20244:48 pmRNSPDMR Dealing
18th Jun 20241:35 pmRNSDirectorate Change
31st May 20247:00 amRNSTotal Voting Rights
23rd May 20247:12 amRNSResponse to CMA announcement
21st May 20247:00 amRNSDisposal of non-core operations
1st May 20247:00 amRNSAppointment of Non-executive Chair
30th Apr 20247:00 amRNSTotal Voting Rights
11th Apr 20245:48 pmRNSStandard form for notification of major holdings
8th Apr 20247:00 amRNSNotice of Cyber Incident
28th Mar 20244:07 pmRNSExercise of Options and Total Voting Rights
12th Mar 20248:06 amRNSResponse to CMA update
29th Feb 20247:00 amRNSExercise of Options and Total Voting Rights
29th Feb 20247:00 amRNSInterim Results
5th Feb 202411:02 amRNSStandard form for notification of major holdings
31st Jan 20247:00 amRNSExercise of Options and Total Voting Rights
29th Jan 20243:41 pmRNSPDMR Dealing
25th Jan 20247:00 amRNSHalf year Trading Update
19th Jan 20242:24 pmRNSExercise of SAYE Options and PDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.